ArticleOncotarget2017
TCTN2: a novel tumor marker with oncogenic properties.
David Cano-Rodriguez et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it
ArticleOncotarget2017
David Cano-Rodriguez et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.